Scleromyxedema in an HCV-positive male
Keywords:
Scleromyxedema, lichen myxedematosus, HCVAbstract
Scleromyxedema is rare chronic cutaneous mucinosis usually associated with a monoclonal gammopathy and underlying systemic disease.We report a 42-year-old male who developed scleromyxedema and was also HCV positive.ÂReferences
Sarkany RPE, Breathnach SM, Seymour CA et al. Metabolic and nutritional disorders. In: Burns T, Breathnach S, Cox N, Griffiths C. Rook’s Textbook of Dermatology.7th edn. London: Blackwell Science; 2004. p. 57.1-83.
Bari AU. Rashid M, Rahman SR. Acral persistent mucinosys: a rare variant of cutaneous mucinoses. J Pak Assoc Dermatol 2004; 14: 253-6.
Banno H, Takamo H, Nitta Y et al. Lichen myxedematosus associated with chronic hepatitis C. Int J Dermatol 2000; 39: 212-4.
Rongioletti F. Lichen myxedematosus (papular mucinoses): new concepts and perspective for an old disease. Semin Cutan Med Surg 2006; 25: 100-4.
Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus and scleromyxedema. J Am Acad Dermatol 2001; 44: 273-81.
Korber A, Frankson T, Graffe S, Dissemond J. Successful therapy of scleromyxedema with low dose intravenous immunoglobulin. J Eur Acad Dermatol Venerol 2007; 21: 553-4.
Rampino M, Garibaldi E, Ragona R, Ricardi U. Scleromyxedema: treatment of widespread cutaneous involvement by total skin electron beam therapy. Int J Dermatol 2007; 46: 864-7.
Lin YC, Wang HC, Shen JL. Scleromyxedema. An experience using corticosteroid and review of the published work. J Am Acad Dermatol 2006; 33: 207-10.
Lo P-Y, Tzung T-Y. Lichen myxedematosus in a patient with hepatocellular carcinoma. Br J Dermatol 2000; 143: 452-3.
Rongioletti F, Rebora A. Worsening of lichen myxedematosus during interferon alfa-2a therapy for chronic active hepatitis C. J Am Acad Dermatol 1998; 38: 760-1.
Masaki S, Nisho Y. Lichen myxedematosus associated with liver cirrhosis. Hihubyou-Shinryou 1994; 16: 29-32 (in Japanese).
